title: Golimumab.
authors.forename: Dimitrios A
authors.initials: DA
authors.lastname: Pappas
authors.forename: Joan M
authors.initials: JM
authors.lastname: Bathon
authors.forename: Delphine
authors.initials: D
authors.lastname: Hanicq
authors.forename: Uma
authors.initials: U
authors.lastname: Yasothan
authors.forename: Peter
authors.initials: P
authors.lastname: Kirkpatrick
mesh_terms: D000911:Antibodies, Monoclonal / Q000494:pharmacology / Q000627:therapeutic use*; D001168:Arthritis / Q000188:drug therapy*; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D004359:Drug Therapy, Combination; D006801:Humans; D008727:Methotrexate / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D013167:Spondylitis, Ankylosing / Q000188:drug therapy; D000079424:Tumor Necrosis Factor Inhibitors; D048069:Tumor Necrosis Factors / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D000079424:Tumor Necrosis Factor Inhibitors; D048069:Tumor Necrosis Factors; C529000:golimumab; D008727:Methotrexate